Cargando…
Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum
Top-down mass spectrometry (MS)-based proteomics provides a comprehensive analysis of proteoforms to achieve a proteome-wide understanding of protein functions. However, the MS detection of low-abundance proteins from blood remains an unsolved challenge due to the extraordinary dynamic range of the...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411019/ https://www.ncbi.nlm.nih.gov/pubmed/32764543 http://dx.doi.org/10.1038/s41467-020-17643-1 |
_version_ | 1783568288926662656 |
---|---|
author | Tiambeng, Timothy N. Roberts, David S. Brown, Kyle A. Zhu, Yanlong Chen, Bifan Wu, Zhijie Mitchell, Stanford D. Guardado-Alvarez, Tania M. Jin, Song Ge, Ying |
author_facet | Tiambeng, Timothy N. Roberts, David S. Brown, Kyle A. Zhu, Yanlong Chen, Bifan Wu, Zhijie Mitchell, Stanford D. Guardado-Alvarez, Tania M. Jin, Song Ge, Ying |
author_sort | Tiambeng, Timothy N. |
collection | PubMed |
description | Top-down mass spectrometry (MS)-based proteomics provides a comprehensive analysis of proteoforms to achieve a proteome-wide understanding of protein functions. However, the MS detection of low-abundance proteins from blood remains an unsolved challenge due to the extraordinary dynamic range of the blood proteome. Here, we develop an integrated nanoproteomics method coupling peptide-functionalized superparamagnetic nanoparticles (NPs) with top-down MS for the enrichment and comprehensive analysis of cardiac troponin I (cTnI), a gold-standard cardiac biomarker, directly from serum. These NPs enable the sensitive enrichment of cTnI (<1 ng/mL) with high specificity and reproducibility, while simultaneously depleting highly abundant proteins such as human serum albumin (>10(10) more abundant than cTnI). We demonstrate that top-down nanoproteomics can provide high-resolution proteoform-resolved molecular fingerprints of diverse cTnI proteoforms to establish proteoform-pathophysiology relationships. This scalable and reproducible antibody-free strategy can generally enable the proteoform-resolved analysis of low-abundance proteins directly from serum to reveal previously unachievable molecular details. |
format | Online Article Text |
id | pubmed-7411019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-74110192020-08-17 Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum Tiambeng, Timothy N. Roberts, David S. Brown, Kyle A. Zhu, Yanlong Chen, Bifan Wu, Zhijie Mitchell, Stanford D. Guardado-Alvarez, Tania M. Jin, Song Ge, Ying Nat Commun Article Top-down mass spectrometry (MS)-based proteomics provides a comprehensive analysis of proteoforms to achieve a proteome-wide understanding of protein functions. However, the MS detection of low-abundance proteins from blood remains an unsolved challenge due to the extraordinary dynamic range of the blood proteome. Here, we develop an integrated nanoproteomics method coupling peptide-functionalized superparamagnetic nanoparticles (NPs) with top-down MS for the enrichment and comprehensive analysis of cardiac troponin I (cTnI), a gold-standard cardiac biomarker, directly from serum. These NPs enable the sensitive enrichment of cTnI (<1 ng/mL) with high specificity and reproducibility, while simultaneously depleting highly abundant proteins such as human serum albumin (>10(10) more abundant than cTnI). We demonstrate that top-down nanoproteomics can provide high-resolution proteoform-resolved molecular fingerprints of diverse cTnI proteoforms to establish proteoform-pathophysiology relationships. This scalable and reproducible antibody-free strategy can generally enable the proteoform-resolved analysis of low-abundance proteins directly from serum to reveal previously unachievable molecular details. Nature Publishing Group UK 2020-08-06 /pmc/articles/PMC7411019/ /pubmed/32764543 http://dx.doi.org/10.1038/s41467-020-17643-1 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Tiambeng, Timothy N. Roberts, David S. Brown, Kyle A. Zhu, Yanlong Chen, Bifan Wu, Zhijie Mitchell, Stanford D. Guardado-Alvarez, Tania M. Jin, Song Ge, Ying Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum |
title | Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum |
title_full | Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum |
title_fullStr | Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum |
title_full_unstemmed | Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum |
title_short | Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum |
title_sort | nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411019/ https://www.ncbi.nlm.nih.gov/pubmed/32764543 http://dx.doi.org/10.1038/s41467-020-17643-1 |
work_keys_str_mv | AT tiambengtimothyn nanoproteomicsenablesproteoformresolvedanalysisoflowabundanceproteinsinhumanserum AT robertsdavids nanoproteomicsenablesproteoformresolvedanalysisoflowabundanceproteinsinhumanserum AT brownkylea nanoproteomicsenablesproteoformresolvedanalysisoflowabundanceproteinsinhumanserum AT zhuyanlong nanoproteomicsenablesproteoformresolvedanalysisoflowabundanceproteinsinhumanserum AT chenbifan nanoproteomicsenablesproteoformresolvedanalysisoflowabundanceproteinsinhumanserum AT wuzhijie nanoproteomicsenablesproteoformresolvedanalysisoflowabundanceproteinsinhumanserum AT mitchellstanfordd nanoproteomicsenablesproteoformresolvedanalysisoflowabundanceproteinsinhumanserum AT guardadoalvareztaniam nanoproteomicsenablesproteoformresolvedanalysisoflowabundanceproteinsinhumanserum AT jinsong nanoproteomicsenablesproteoformresolvedanalysisoflowabundanceproteinsinhumanserum AT geying nanoproteomicsenablesproteoformresolvedanalysisoflowabundanceproteinsinhumanserum |